Hockings joins Phylogica board

Phylogica has appointed Bernard Hockings as a director.

Dr Hockings is a cardiologist in Perth and a substantial shareholder in Phylogica, a peptide drug discovery company.

He recently invested $1.8 million in the company, lifting his stake to 22 per cent.